No Data
No Data
One CG Oncology Insider Has Reduced Their Stake
Express News | CG Oncology To Present At Society of Urologic Oncology (SUO) 25th Annual Meeting Dec. 4-6
CG Oncology's Financial Results and Clinical Developments
RBC Capital Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $66
Analysts Offer Insights on NA Companies: CG Oncology, Inc. (CGON), Smith Douglas Homes Corp. Class A (SDHC) and Palmer Square Capital BDC Inc. (PSBD)
CG Oncology | 10-Q: Q3 2024 Earnings Report